EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Oral Manifestations of Inflammatory Bowel Disease and the Role of Non-Invasive Surrogate Markers of Disease Activity

Davide Giuseppe Ribaldone iD, Selvaggia Brigo, Michela Mangia, Giorgio Maria Saracco iD, Marco Astegiano, Rinaldo Pellicano iD

Medicines · 16.06.2020 · 7 (6) · 33

DOI: 10.3390/medicines7060033 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Medicines, online erschienen am 16.06.2020. Verfasst von Davide Giuseppe Ribaldone und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Sciences, University of Turin, 10126 Turin, Italy. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammatory bowel disease (IBD), which includes Crohn’s disease (CD) and ulcerative colitis (UC), can be associated with several extra-intestinal manifestations requiring a multidisciplinary management both in terms of work-up and therapy. Oral lesions are common in patients with IBD, with a prevalence ranging from 5% to 50%. These can represent an oral location of IBD as well as a side-effect of drugs used to treat the intestinal disease. Oral manifestations, occurring in patients with IBD, can be divided in nonmalignant, specific, and non-specific ones, and malignant lesions. While there is undoubtedly a need to search for an IBD in patients with oral lesions associated with intestinal symptoms, the work-up of those with an exclusive oral lesion should be personalized. Fecal calprotectin is a non-invasive marker of intestinal inflammation and may be used to select which patients need to undergo endoscopic examination, thereby avoiding unnecessary investigations. The pharmacological armamentarium to treat oral lesions associated with IBD includes topical or systemic corticosteroids, immunosuppressive agents, and biologic drugs.

Schlagwörter

Stichwörter der Autor:innen

Crohn’s diseaseaphthous stomatitiscobblestoningextra-intestinal manifestationsinflammatory bowel diseaselip swellingmucogingivitisorofacial granulomatosistag-like lesionsulcerative colitis

Autor:innen und Institutionen

  • Department of Medical Sciences, University of Turin, 10126 Turin, Italy.
  • Bow Lane Dental Group, St George's Hospital, Bupa Dental Care, London SW17 0QT, UK.
  • Unit of Gastroenterology, Molinette Hospital, 10126 Turin, Italy.

ORCID-Profile: Davide Giuseppe Ribaldone, Giorgio Maria Saracco, Rinaldo Pellicano

Zitieren

APA

Ribaldone, D. G., Brigo, S., Mangia, M., Saracco, G. M., Astegiano, M., & Pellicano, R. (2020). Oral Manifestations of Inflammatory Bowel Disease and the Role of Non-Invasive Surrogate Markers of Disease Activity. Medicines, 7(6), 33. https://doi.org/10.3390/medicines7060033

Vancouver

Ribaldone DG, Brigo S, Mangia M, Saracco GM, Astegiano M, Pellicano R. Oral Manifestations of Inflammatory Bowel Disease and the Role of Non-Invasive Surrogate Markers of Disease Activity. Medicines. 2020;7(6):33. doi:10.3390/medicines7060033

BibTeX
@article{Ribaldone2020,
  author = {Ribaldone, Davide Giuseppe and Brigo, Selvaggia and Mangia, Michela and Saracco, Giorgio Maria and Astegiano, Marco and Pellicano, Rinaldo},
  title = {Oral Manifestations of Inflammatory Bowel Disease and the Role of Non-Invasive Surrogate Markers of Disease Activity},
  journal = {Medicines},
  year = {2020},
  volume = {7},
  number = {6},
  pages = {33},
  doi = {10.3390/medicines7060033}
}
Kostenlos starten →